8VC

Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Even is a health tech company and healthcare provider that partners directly with the top hospitals in the country to offer you unlimited diagnostics, consultations, and 50 lakh worth of hospitalisations all with one monthly subscription cost.

Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Our mission is to redefine the standard of care in pulmonary medicine and deliver the best lung care in America. We’re rebuilding the pulmonary clinic around a technology platform and a set of virtual and physical interventions calibrated to keep lung conditions under control. At a Nimbus Clinic, rich patient data and predictive models allow our providers to make more thoughtful medical decisions, and step in at exactly the right moment.

Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing the quality, accessibility, and affordability of healthcare through advanced technology. Founded in 2010 in Coralville, Iowa, by Michael Abramoff, the company has developed a range of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration. Additionally, Digital Diagnostics provides algorithms for detecting other conditions such as Alzheimer's disease and cardiovascular risks. By eliminating the diagnostic burden from specialists, the company's AI platform aims to establish a new standard of care, democratizing healthcare and improving patient outcomes. The company collaborates with patient advocacy groups and regulatory bodies to facilitate the adoption of its innovative solutions both in the United States and internationally.

Candid Health is a platform that automates revenue cycle management for healthcare providers, facilitating efficient tracking of claims and management of billing processes. Utilizing machine learning and artificial intelligence, the platform streamlines medical billing, coding, and claims processing, thereby reducing administrative burdens and enhancing operational efficiency. By offering end-to-end automation, Candid Health optimizes financial operations for clinics and hospitals, allowing healthcare providers to concentrate on delivering quality, affordable, and accessible care while ensuring faster service reimbursement. The platform seamlessly integrates with existing systems, providing modern tools that simplify the complexities of medical billing and improve overall patient experiences.

Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.

Ritten operates an electronic medical records platform designed specifically for addiction treatment providers to enhance the quality of care for their patients. The platform facilitates personalized, data-informed care by offering customized workflow configurations that support the consistent and compliant delivery of complex treatment. It enables clinicians and administrators to maintain comprehensive patient records that encompass all aspects of a patient's care, including clinical notes, medications, and treatment plans. This approach allows healthcare professionals to provide tailored care while effectively tracking patient progress and needs.

Pair Team focuses on enhancing primary care infrastructure for vulnerable communities, particularly those served by safety-net systems, Medicaid, and Medicare patients. As a tech-enabled care team, it extends the capabilities of clinical staff by offering personalized, high-touch care experiences. The organization addresses various barriers to healthcare, including transportation issues, housing and food insecurity, and limited mobile access. Pair Team employs a dedicated care team consisting of community health workers, registered nurses, and behavioral health clinicians to deliver comprehensive support tailored to the needs of low-income individuals. Additionally, the company is developing a care delivery platform designed to implement clinical best practices, integrate services with community-based organizations, and streamline administrative tasks, allowing clinicians to dedicate more time to patient care.

Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Examedi is a healthcare startup that provides nurse and lab technician services directly at patients' homes for appointments. Examedi connects the availabilities of healthcare providers with patients.

Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.

SummerBio LLC is an automation-based diagnostics company focused on providing COVID-19 testing services. Established in 2020 and based in Menlo Park, California, the company operates a CLIA-certified laboratory that utilizes a comprehensive, automated COVID-19 testing system. This system is designed to enhance the efficiency of the gold-standard RT-qPCR testing regimen by using advanced robotics, automated liquid handling, and innovative sample collection kits. By streamlining the testing process, SummerBio aims to deliver rapid, affordable, and high-volume testing solutions, ensuring that healthcare professionals and patients receive test results within a day.

Avail Medsystems, Inc. is a digital healthcare company that develops a platform designed to remotely connect healthcare experts with practitioners. The company's integrated audio/visual hardware and software system facilitates procedural support, observation, and clinical education services, allowing healthcare professionals to collaborate effectively. By enabling real-time access to clinical expertise, Avail aims to eliminate physical, economic, and logistical barriers in the healthcare industry. This approach promotes innovation and enhances the adoption of medical tools and techniques, ultimately improving patient care. Founded in 2017 and based in Palo Alto, California, Avail Medsystems was previously known as Nurep, Inc. and underwent a name change in March 2018.

Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.

Nines is a pioneering teleradiology practice that focuses on enhancing patient care through advanced technology. The company develops in-house tools that empower radiologists to provide high-quality diagnostics. Its platform is designed to analyze medical scans for urgent findings that necessitate immediate attention, as well as to identify subtle details that assist in the radiological review process. This innovative approach aims to improve the accuracy of results and overall patient care, setting Nines apart in the field of radiology.

Digital Diagnostics Inc. is an artificial intelligence diagnostics company focused on enhancing the quality, accessibility, and affordability of healthcare through advanced technology. Founded in 2010 in Coralville, Iowa, by Michael Abramoff, the company has developed a range of autonomous algorithms that analyze medical images to detect various diseases. Its flagship products include IDx-DR for diabetic retinopathy, IDx-G for glaucoma indicators, and IDx-AMD for age-related macular degeneration. Additionally, Digital Diagnostics provides algorithms for detecting other conditions such as Alzheimer's disease and cardiovascular risks. By eliminating the diagnostic burden from specialists, the company's AI platform aims to establish a new standard of care, democratizing healthcare and improving patient outcomes. The company collaborates with patient advocacy groups and regulatory bodies to facilitate the adoption of its innovative solutions both in the United States and internationally.

uBiome, Inc. was a microbial genomics company based in San Francisco, California, specializing in sequencing-based clinical microbiome tests. Founded in 2012, it offered a range of products including SmartGut, a test for identifying harmful and beneficial microorganisms linked to specific infections; SmartJane, a women’s health screening for conditions like HPV and STIs; Explorer kits for researchers and citizen scientists; and SmartFlu, a clinical test for respiratory infections. The company's goal was to enhance understanding of the human microbiome and its implications for health. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019, marking the end of its operations.

Opencare Inc. operates a healthcare discovery platform that connects patients with healthcare providers in North America, primarily focusing on dental services. Founded in 2012 and based in Toronto, Canada, the company's platform allows users to find and book appointments online with a variety of healthcare professionals, including dentists, chiropractors, massage therapists, physiotherapists, and optometrists. By transforming the dental industry, Opencare aims to provide patients with confidence in receiving high-quality care while also facilitating practice growth for top dentists. The platform streamlines interactions between patients and providers, ensuring a convenient and rewarding experience for all users. Opencare was previously known as HealthKiwi Inc. before rebranding in March 2018.

Notable is an AI-driven platform designed to enhance healthcare operations and improve physician-patient interactions. Deployed at over 10,000 care sites, it automates more than a million repetitive workflows daily, including processes related to registration, scheduling, authorizations, and chart reviews. The platform features a voice-powered application that organizes physician-patient conversations and dictations while securely recommending appropriate billing codes. By streamlining these tasks, Notable reduces manual workload for caregivers and fosters personalized care for patients, ultimately contributing to better financial health for healthcare providers.

100Plus is a rapidly growing remote patient monitoring platform designed to enhance the care of elderly patients with chronic conditions. The platform provides comprehensive services, including patient outreach, device setup, patient engagement, and automatic billing, all integrated with medical devices. By enabling doctors to monitor high-risk seniors remotely, 100Plus helps to prevent costly episodic care and promotes a higher quality of life for patients. When a Medicare patient receives a 100Plus medical device, it is delivered at no cost to them or their healthcare providers, fully configured and ready for immediate use, eliminating the need for smartphones, apps, Bluetooth, or WiFi.

Coral Genomics, Inc. is a biotechnology company based in San Francisco, California, founded in 2018. The company specializes in optimizing drug development and deployment through the use of genomic data derived from patients. Coral Genomics focuses on creating new clinical tests that assist healthcare providers in streamlining prior authorization processes and selecting effective medications tailored to individual patients, particularly those with autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. Additionally, the company has identified a distinct population of non-responder patients and collaborates with drug developers to address their unmet medical needs.

uBiome, Inc. was a microbial genomics company based in San Francisco, California, specializing in sequencing-based clinical microbiome tests. Founded in 2012, it offered a range of products including SmartGut, a test for identifying harmful and beneficial microorganisms linked to specific infections; SmartJane, a women’s health screening for conditions like HPV and STIs; Explorer kits for researchers and citizen scientists; and SmartFlu, a clinical test for respiratory infections. The company's goal was to enhance understanding of the human microbiome and its implications for health. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019, marking the end of its operations.